These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 2509395

  • 1. Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor.
    Robison WG, Nagata M, Laver N, Hohman TC, Kinoshita JH.
    Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2285-92. PubMed ID: 2509395
    [Abstract] [Full Text] [Related]

  • 2. Diabetes-related histopathologies of the rat retina prevented with an aldose reductase inhibitor.
    Robison WG, Tillis TN, Laver N, Kinoshita JH.
    Exp Eye Res; 1990 Apr; 50(4):355-66. PubMed ID: 2110907
    [Abstract] [Full Text] [Related]

  • 3. Aldose reductase and pericyte-endothelial cell contacts in retina and optic nerve.
    Robison WG, Nagata M, Tillis TN, Laver N, Kinoshita JH.
    Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2293-9. PubMed ID: 2509396
    [Abstract] [Full Text] [Related]

  • 4. Aldose reductase, diabetes, and thickening of the retinal inner limiting membrane.
    Nagata M, Robison WG.
    Invest Ophthalmol Vis Sci; 1987 Nov; 28(11):1867-9. PubMed ID: 3117719
    [Abstract] [Full Text] [Related]

  • 5. Galactose-induced retinal microangiopathy in rats.
    Kern TS, Engerman RL.
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):490-6. PubMed ID: 7843917
    [Abstract] [Full Text] [Related]

  • 6. Sorbinil prevention of diabetic-like retinopathy in the galactose-fed rat model.
    Robison WG, Laver NM, Jacot JL, Glover JP.
    Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2368-80. PubMed ID: 7591626
    [Abstract] [Full Text] [Related]

  • 7. Effects of aldose reductase inhibitor on retinal microangiopathy in streptozotocin-diabetic rats.
    Kojima K, Matsubara H, Harada T, Mizuno K, Suzuki M, Hotta N, Kakuta H, Sakamoto N.
    Jpn J Ophthalmol; 1985 Nov; 29(1):99-109. PubMed ID: 3159927
    [Abstract] [Full Text] [Related]

  • 8. The polyol pathway in retinal microangiopathy.
    Robison WG, Kinoshita JH, Kador PF.
    Drugs; 1986 Nov; 32 Suppl 2():19-22. PubMed ID: 3098542
    [Abstract] [Full Text] [Related]

  • 9. Prevention of basement membrane thickening in retinal capillaries by a novel inhibitor of aldose reductase, tolrestat.
    Robison WG, Kador PF, Akagi Y, Kinoshita JH, Gonzalez R, Dvornik D.
    Diabetes; 1986 Mar; 35(3):295-9. PubMed ID: 3081393
    [Abstract] [Full Text] [Related]

  • 10. Aldose reductase and retinal capillary basement membrane thickening.
    Robison WG, Nagata M, Kinoshita JH.
    Exp Eye Res; 1988 Mar; 46(3):343-8. PubMed ID: 3127228
    [Abstract] [Full Text] [Related]

  • 11. Amelioration of diabetes-like retinal changes in galactose-fed dogs.
    Kador PF, Takahashi Y, Sato S, Wyman M.
    Prev Med; 1994 Sep; 23(5):717-21. PubMed ID: 7845946
    [Abstract] [Full Text] [Related]

  • 12. Retinal capillary dilation: early diabetic-like retinopathy in the galactose-fed rat model.
    Glover JP, Jacot JL, Basso MD, Hohman TC, Robison WG.
    J Ocul Pharmacol Ther; 2000 Apr; 16(2):167-72. PubMed ID: 10803427
    [Abstract] [Full Text] [Related]

  • 13. Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors.
    Kador PF, Akagi Y, Takahashi Y, Ikebe H, Wyman M, Kinoshita JH.
    Arch Ophthalmol; 1990 Sep; 108(9):1301-9. PubMed ID: 2119169
    [Abstract] [Full Text] [Related]

  • 14. Increases in collagen type IV and laminin in galactose-induced retinal capillary basement membrane thickening--prevention by an aldose reductase inhibitor.
    Das A, Frank RN, Zhang NL, Samadani E.
    Exp Eye Res; 1990 Mar; 50(3):269-80. PubMed ID: 2108050
    [Abstract] [Full Text] [Related]

  • 15. Polyol formation and NADPH-dependent reductases in dog retinal capillary pericytes and endothelial cells.
    Sato S, Secchi EF, Lizak MJ, Fukase S, Ohta N, Murata M, Tsai JY, Kador PF.
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):697-704. PubMed ID: 10067973
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of treatment after measurable diabeticlike retinopathy in galactose-fed rats.
    Robison WG, Laver NM, Jacot JL, Chandler ML, York BM, Glover JP.
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1066-73. PubMed ID: 9152226
    [Abstract] [Full Text] [Related]

  • 17. Effect of aldose reductase inhibitors on the progression of retinopathy in galactose-fed dogs.
    Akagi Y, Kador PF.
    Exp Eye Res; 1990 Jun; 50(6):635-9. PubMed ID: 2115453
    [Abstract] [Full Text] [Related]

  • 18. Prevention of diabetes-related retinal microangiopathy with aldose reductase inhibitors.
    Robison WG.
    Adv Exp Med Biol; 1988 Jun; 246():365-72. PubMed ID: 3150650
    [Abstract] [Full Text] [Related]

  • 19. [Prevention of pericyte ghost formation in retinal capillaries by aldose reductase inhibitor in galactose-fed dogs with diabetic retinopathy].
    Akagi Y, Terubayashi H, Ikebe H, Kador PF, Kinoshita JH.
    Nippon Ganka Gakkai Zasshi; 1988 Sep; 92(9):1479-84. PubMed ID: 3145681
    [No Abstract] [Full Text] [Related]

  • 20. An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia.
    Frank RN, Amin R, Kennedy A, Hohman TC.
    Arch Ophthalmol; 1997 Aug; 115(8):1036-47. PubMed ID: 9258227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.